FMP
Ovoca Bio plc
OVXA.IR
EURONEXT
Inactive Equity
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
0.006 EUR
-0.0005 (-8.33%)
About
ceo
Mr. Kirill Andreyevich Golovanov
sector
Healthcare
industry
Biotechnology
website
https://ovocabio.com
exchange
EURONEXT
Description
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
CIK
N/A
ISIN
N/A
CUSIP
N/A
Address
17 Pembroke Street Upper
Phone
353 1 661 9819
Country
IE
Employee
5
IPO Date
Jun 27, 2000
Key Executives
